These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15725047)

  • 1. Rhinitis medicamentosa: a review of causes and treatment.
    Graf P
    Treat Respir Med; 2005; 4(1):21-9. PubMed ID: 15725047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhinitis medicamentosa: aspects of pathophysiology and treatment.
    Graf P
    Allergy; 1997; 52(40 Suppl):28-34. PubMed ID: 9353558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
    Graf P
    Clin Ther; 1999 Oct; 21(10):1749-55. PubMed ID: 10566570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
    Graf P; Hallén H
    Laryngoscope; 1996 May; 106(5 Pt 1):605-9. PubMed ID: 8628089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhinitis medicamentosa: the forgotten factor in nasal obstruction.
    Mabry RL
    South Med J; 1982 Jul; 75(7):817-9. PubMed ID: 6178170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzalkonium chloride in a decongestant nasal spray aggravates rhinitis medicamentosa in healthy volunteers.
    Graf P; Hallén H; Juto JE
    Clin Exp Allergy; 1995 May; 25(5):395-400. PubMed ID: 7553241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rhinitis medicamentosa in cytological assessment of the nasal mucosa].
    Tarchalska B; Gotlib T; Samoliński B
    Pol Merkur Lekarski; 2005 Sep; 19(111):288-90. PubMed ID: 16358845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhinitis medicamentosa: what an otolaryngologist needs to know.
    Doshi J
    Eur Arch Otorhinolaryngol; 2009 May; 266(5):623-5. PubMed ID: 19096862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Daily administration of nose drops can cause chronic nasal congestion].
    Graf P; Hallén H
    Lakartidningen; 1996 Jan; 93(4):259-62. PubMed ID: 8569350
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research progress on rhinitis medicamentosa].
    Wang YN; Luan ZL; Wang HT
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):872-875. PubMed ID: 29141305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions.
    Marple B; Roland P; Benninger M
    Otolaryngol Head Neck Surg; 2004 Jan; 130(1):131-41. PubMed ID: 14726922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinitis medicamentosa.
    Ramey JT; Bailen E; Lockey RF
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Rhinitis Medicamentosa: A Systematic Review.
    Zucker SM; Barton BM; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):429-438. PubMed ID: 30325708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling.
    Graf P; Juto JE
    Rhinology; 1995 Mar; 33(1):14-7. PubMed ID: 7540314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa.
    Hallén H; Enerdal J; Graf P
    Clin Exp Allergy; 1997 May; 27(5):552-8. PubMed ID: 9179430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.